5-Amino-2,3-Dihydrobenzofuran in Kinase Inhibitor Scaffold Synthesis

Overcoming Acylation Hurdles of 5-Amino-2,3-dihydrobenzofuran in CNS Kinase Inhibitor Synthesis

In the synthesis of CNS-penetrant kinase inhibitors, the 2,3-dihydrobenzofuran core is a privileged scaffold due to its balanced lipophilicity and metabolic stability. The primary amine at the 5-position, formally named 2,3-dihydro-1-benzofuran-5-amine, serves as a critical handle for introducing diverse pharmacophores via amide bond formation. However, process chemists frequently encounter sluggish acylation kinetics when using standard coupling reagents like HATU or EDCI. This is not a reactivity issue of the amine itself, but rather a consequence of the electron-rich benzofuran oxygen, which can transiently coordinate to the acylating agent, reducing its electrophilicity. In our hands, pre-activation of the carboxylic acid with CDI in THF at 0–5°C, followed by slow addition of 5-Amino-2,3-dihydrobenzo[b]furan, consistently delivers >95% conversion within 2 hours. This protocol avoids the formation of the N-acylurea byproduct often observed with carbodiimide reagents. For multi-kilogram campaigns, we recommend a simple aqueous workup to remove imidazole, yielding the amide in high purity without chromatography. This approach has been successfully applied to the synthesis of a clinical-stage Trk inhibitor, where the dihydrobenzofuran moiety is essential for maintaining the desired hinge-binding orientation.

Solvent Incompatibility and Low-Temperature Processing: Mitigating Premature Cyclization and Tar Formation

A less documented but operationally critical challenge is the sensitivity of 5-Amino-2,3-dihydrobenzofuran to chlorinated solvents under acidic conditions. When attempting to form the hydrochloride salt in dichloromethane, we observed a gradual color change from pale yellow to deep amber, accompanied by the formation of a viscous tar. This is attributed to acid-catalyzed ring-opening of the dihydrofuran, followed by oligomerization. To circumvent this, we strictly avoid halogenated solvents for any step involving strong acids. Instead, we recommend using ethereal solvents like 2-MeTHF or MTBE for salt formation. For reactions requiring low temperatures (e.g., lithiation or Grignard additions), the free base exhibits excellent solubility in anhydrous THF down to -78°C without precipitation. However, a non-standard parameter to monitor is the viscosity of concentrated solutions at sub-zero temperatures. At -40°C, a 2 M solution in THF becomes noticeably more viscous than analogous aniline derivatives, which can impact mixing efficiency in jacketed reactors. We advise process engineers to account for this by increasing agitation speed or diluting to 1.5 M to maintain homogeneous heat transfer. This field observation is rarely captured in standard COAs but is crucial for safe scale-up.

Drop-in Replacement Strategies for 5-Amino-2,3-dihydrobenzofuran in Scale-Up Campaigns

For R&D managers evaluating second sources, our 2,3-Dihydrobenzofuran-5-amine is manufactured to function as a true drop-in replacement for established catalog products. We have conducted head-to-head comparative studies against material from major suppliers in a model Suzuki-Miyaura coupling with 4-cyanophenylboronic acid. The reaction profiles, as monitored by HPLC, were superimposable, with identical conversion rates and impurity fingerprints. The key differentiator is our supply chain resilience: we maintain a safety stock of 500 kg in our Ningbo facility, ensuring uninterrupted delivery even during global logistics disruptions. Our high purity grade consistently exceeds 99% by HPLC, with single impurity levels below 0.5%. For teams transitioning from a competitor's material, we provide a detailed analytical bridging study to support regulatory filings. This includes comparative NMR, LCMS, and residual solvent profiles. As discussed in our article on Drop-In Replacement For Sigma-Aldrich Cpr Grade 5-Amino-2,3-Dihydrobenzofuran, the physical properties and reactivity are indistinguishable, allowing for a seamless switch without revalidation of downstream chemistry. For German-speaking clients, we also offer a detailed technical note: Drop-In-Ersatz Für Sigma-Aldrich Cpr-Qualität 5-Amino-2,3-Dihydrobenzofuran.

Non-Standard Parameter Insights: Viscosity Shifts and Crystallization Behavior in Polar Aprotic Media

Beyond the standard specifications, experienced process chemists will appreciate the nuanced behavior of this organic building block in polar aprotic solvents. While the free base is a low-melting solid (mp 48–52°C), it exhibits a pronounced tendency to supercool, often remaining as a viscous oil for days at room temperature. This can complicate dispensing in automated synthesis platforms. To induce crystallization, we recommend seeding with a few milligrams of authentic crystalline material and storing at -20°C for 4–6 hours. Once crystallized, the material is free-flowing and easy to handle. Another field note concerns trace impurities that can affect color in sensitive applications. We have observed that exposure to air for prolonged periods can lead to a slight pink discoloration, which is not indicative of purity loss but can be problematic for color-sensitive formulations. Our manufacturing process includes a final sublimation step under high vacuum to remove these trace chromophores, ensuring a consistent white to off-white appearance. Please refer to the batch-specific COA for exact color and clarity specifications. For amide bond formation, the moisture content is a critical quality attribute; we guarantee ≤0.1% water by Karl Fischer titration, which is essential for reproducible yields in moisture-sensitive coupling reactions.

Supply Chain Reliability and Cost-Efficiency: NINGBO INNO PHARMCHEM as Your Strategic Partner

As a dedicated global manufacturer of heterocyclic intermediates, NINGBO INNO PHARMCHEM has optimized the synthesis route of 5-Amino-2,3-dihydrobenzofuran to achieve a cost position that enables competitive bulk price offerings without compromising quality. Our manufacturing process starts from readily available 2,3-dihydrobenzofuran, which is nitrated and then hydrogenated under mild conditions to avoid over-reduction of the furan ring. This three-step sequence is run in dedicated stainless steel reactors with a capacity of 3,000 L, allowing us to produce multi-ton quantities annually. For clients requiring custom synthesis of derivatives, our R&D team can rapidly develop and scale processes for N-alkylated, sulfonylated, or halogenated analogs. We understand that in pharmaceutical synthesis, consistency is paramount. Therefore, every batch is accompanied by a comprehensive COA that includes assay, impurity profile, residual solvents, and heavy metals. Our logistics team specializes in the safe handling of amine intermediates; we ship in 210L steel drums with PTFE-lined closures to prevent moisture ingress, or in 1,000 L IBCs for bulk orders. We do not claim any specific environmental certifications, but we adhere to rigorous internal quality management systems to ensure product integrity from batch to batch.

Frequently Asked Questions

What are the optimal coupling reagents for amide bond formation with 5-Amino-2,3-dihydrobenzofuran?

For small-scale reactions, HATU with DIPEA in DMF works well, but for scale-up, we recommend CDI pre-activation of the carboxylic acid in THF. This minimizes racemization and avoids the formation of the N-acylurea byproduct. EDCI/HOBt is also effective but may require longer reaction times. Always ensure the amine is free-based before coupling if using a salt form.

What is the critical moisture threshold for reproducible amide bond formation?

Moisture levels above 0.2% can significantly reduce yields in amide couplings, especially when using acid chlorides or chloroformates. Our specification of ≤0.1% water by KF titration ensures consistent performance. We recommend storing the material under nitrogen and using freshly opened containers for critical steps.

How can I optimize yields during multi-gram synthesis of kinase inhibitor intermediates?

Yield optimization often hinges on controlling the exotherm during acylation. We suggest the following step-by-step troubleshooting process:

• Step 1: Verify the purity of the starting 5-Amino-2,3-dihydrobenzofuran by HPLC. Impurities like the over-reduced tetrahydrobenzofuran can act as chain terminators.
• Step 2: Pre-dry all glassware and solvents. Use anhydrous THF or DMF with sure-seal packaging.
• Step 3: For CDI-mediated couplings, ensure the carboxylic acid is fully converted to the acylimidazole before adding the amine. Monitor by TLC or IR for the characteristic imidazolide carbonyl stretch at 1820 cm⁻¹.
• Step 4: Add the amine as a solution in THF over 30 minutes at 0–5°C to avoid localized hot spots that can lead to byproduct formation.
• Step 5: After complete addition, allow the reaction to warm to room temperature and stir for an additional 2 hours. Quench with water and extract with ethyl acetate. The product amide is often crystalline and can be purified by simple trituration.

Sourcing and Technical Support

When sourcing 5-Amino-2,3-dihydrobenzofuran for your kinase inhibitor programs, partnering with a reliable manufacturer is as critical as the chemistry itself. NINGBO INNO PHARMCHEM offers not only a high-quality product but also the technical expertise to support your process development. Our team includes PhD chemists with hands-on experience in heterocyclic chemistry, ready to assist with troubleshooting or custom synthesis requests. We understand the pressures of drug development timelines and offer flexible supply agreements, including safety stock consignment. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.